Loading data
BELFANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 675.46 m USD | 534.79 m USD | 639.81 m USD | 654.23 m USD | 543.49 m USD |
| Cost of revenue | 411.04 m USD | 332.43 m USD | 423.96 m USD | 470.78 m USD | 409.11 m USD |
| Gross profit | 264.42 m USD | 202.36 m USD | 215.85 m USD | 183.45 m USD | 134.38 m USD |
| Research and development expense | 30.9 m USD | 23.6 m USD | 22.5 m USD | 20.2 m USD | 21.9 m USD |
| Selling, general and administrative expense | 125.83 m USD | 110.62 m USD | 99.09 m USD | 92.34 m USD | 86.61 m USD |
| Operating profit | 111 m USD | 64.3 m USD | 87.98 m USD | 65.15 m USD | 31.26 m USD |
| Interest expense | — | — | 2.85 m USD | 3.38 m USD | 3.54 m USD |
| Profit before tax | 95.05 m USD | 61.81 m USD | 83.3 m USD | 59.06 m USD | 27.33 m USD |
| Income tax expense | 20.94 m USD | 12.62 m USD | 9.47 m USD | 6.37 m USD | 2.51 m USD |
| Net income (reported basis) | 61.54 m USD | 40.96 m USD | 73.83 m USD | 52.69 m USD | 24.82 m USD |
| Net income attributable to common shareholders | 61.54 m USD | 40.96 m USD | 73.83 m USD | 52.69 m USD | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.